Seres Therapeutics, Inc. (MCRB) - Stock Prices, Stock Peers & Analysis

Home
MCRB

Company Name	Seres Therapeutics, Inc.
Symbol	MCRB
Currency	USD
Price	0.954
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	145,357,190
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.54 - 3.275
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Eric D. Shaff M.B.A.
Website	https://www.serestherapeutics.com

An error occurred while fetching data.

About Seres Therapeutics, Inc.

Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment